Dr Joël Jean-Mairet PhD

Bio

Joël oversees all operations at Ysios Capital Partners, including management, strategy and standard operations. Joël co-founded GLYCART Biotechnology AG (Zürich, Switzerland) in March 2001 and was Chief Executive since inception. He raised €15 million in three rounds of financing for GLYCART before the company was sold to F.Hoffmann-La Roche Ltd in July 2005. As CEO of GLYCART, he led all the fund-raising efforts, established a pan-European investment syndicate with leading venture capital firms and structured, negotiated and executed several key in- and out-licensing agreements with global pharmaceutical and biotechnology companies, and key technology transfer agreements. Joël holds a master's degree in Biochemistry, specializing in Biotechnology, and a doctorate in the fields of cell biology and immunotherapeutics, both from the Swiss Federal Institute of Technology in Zürich. He was elected one of the 50 key players in biotechnology in Switzerland in 2003 and earned several innovation awards for GLYCART, including the Wall Street Journal Europe Innovation Award in 2001. The GLYCART-Roche transaction was lauded by European Venture Capital magazine as the "Venture Deal of the Year" (2005) in the Healthcare category.